Quarterly report pursuant to Section 13 or 15(d)

Related-Party Transactions

v3.2.0.727
Related-Party Transactions
6 Months Ended
Jun. 30, 2015
Related Party Transactions [Abstract]  
Related-Party Transactions
Related-Party Transactions
The Company had transactions with related parties as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2015
 
2014
 
2015
 
2014
Revenue
$
988

 
$
1,822

 
$
1,975

 
$
3,644

Selling, general and administrative expense
$

 
$
500

 
$

 
$
500


Sanofi owns 100% of a subsidiary that is a customer of the Company's Services Business, which is presented in discontinued operations in the accompanying statements of operations (Note 14). Both Sanofi and the subsidiary have an investment in the Company. The Company’s related-party revenue with the subsidiary composed 27% and 29% total revenue in discontinued operations for the three and six months ended June 30, 2015, respectively, and 40% and 40% of total revenue in discontinued operations for the three and six months ended June 30, 2014, respectively.
In May 2014, the Company paid a $500 IPO success fee to Burrill Securities, an affiliate of Burrill Biotechnology Capital Fund, L.P., a holder of the Company’s capital stock, pursuant to the engagement letter, as amended. The fee was recognized as general and administrative expense in the accompanying statements of operations.